(105 days)
Not Found
Not Found
No
The device description focuses on the mechanical aspects of the catheter and its accessories for manual extraction. There is no mention of any computational or analytical capabilities that would suggest the use of AI/ML.
Yes.
The device is used to remove emboli and thrombi, which are medical conditions, from vessels in the arterial system, thus treating a disease.
No
The device is described as an "extraction catheter" for "removal of fresh, soft emboli and thrombi," indicating a therapeutic rather than diagnostic purpose. While it can filter blood "for laboratory analysis of thrombus," its primary function is not to diagnose.
No
The device description clearly details a physical catheter with lumens, accessories (syringe, extension line, stopcock, filter basket), and a radiopaque marker. This indicates a hardware-based medical device, not a software-only one.
Based on the provided information, the Pronto™ Extraction Catheter is not an In Vitro Diagnostic (IVD) device.
Here's why:
- Intended Use: The intended use is the removal of emboli and thrombi from vessels in the arterial system. This is a therapeutic procedure performed in vivo (within the living body).
- Device Description: The description details a catheter designed for physical extraction of material from within blood vessels.
- Lack of Diagnostic Function: The device does not perform any tests on samples in vitro (outside the body) to diagnose a condition, monitor a treatment, or screen for a disease. While a filter basket is included for laboratory analysis of the removed thrombus, the catheter itself is not performing the diagnostic test. The analysis of the thrombus would be a separate IVD process.
IVD devices are typically used to examine specimens such as blood, urine, or tissue to provide information for diagnosis, monitoring, or screening. The Pronto™ Extraction Catheter is a medical device used for a therapeutic intervention.
N/A
Intended Use / Indications for Use
The Pronto™ Extraction Catheter is indicated for the removal of fresh, soft emboli and thrombi from vessels in the arterial system.
Product codes
QEZ, DXE
Device Description
The Pronto extraction catheter is a dual lumen catheter with related accessories. The extraction lumen allows for the aspiration and removal of emboli/thrombi using the included syringe, extension line and stopcock. The catheter has a rounded distal tip with a protected, sloped opening of the extraction lumen to facilitate advancement of the catheter into the blood vessel and maximize extraction of emboli/thrombi through the extraction lumen. Incorporated within the catheter distal tip is a non-blood contacting radiopaque marker for fluoroscopic visualization. The catheter is a monorail design with a distal flexible region and a proximal stiff region. The distal portion of the catheter is coated with Tween (Polysorbate 80); this coating is to lubricate the catheter for ease of use. The catheter has an approximate outer diameter of 0.065 inches, allowing delivery through standard 6Ft. guide catheters. The smaller wire lumen of the catheter is able to accommodate guide wires that are ≤ 0.014" in diameter. The catheter will be available in working lengths of 40 to 145 cm, in increments of 15 cm. The proximal end of the catheter incorporates a standard luer adapter to facilitate the attachment of the catheter to the included extension line, stopcock, and syringe. A 74 micron filter basket is included for assistance in filtering the blood removed during the procedure for laboratory analysis of thrombus.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
vessels in the arterial system
Indicated Patient Age Range
Not Found
Intended User / Care Setting
PRESCRIPTION USE
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Summary of Non-Clinical Testing:
Testing conducted included assessments of the design verification of the Pronto Extraction Festange with biocompatibility assessments. The results of this battery of tests confirmed the suitability of the Pronto Extraction Catheter for its intended use.
Summary of Clinical Testing:
No clinical evaluations of this product have been conducted.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Fogarty Thru-Lumen Embolectorny Catheter, American Biomed Embolectomy Catheter, LeMaitre Embolectomy Catheter
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.5150 Embolectomy catheter.
(a)
Identification. An embolectomy catheter is a balloon-tipped catheter that is used to remove thromboemboli, i.e., blood clots which have migrated in blood vessels from one site in the vascular tree to another.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
October 8, 2021
Vascular Solutions, Inc. Gregory Sachs Director Of Regulatory Affairs 6464 Sycamore Court Minneapolis, Minnesota 55369
Re: K032763
Trade/Device Name: Vascular Solutions Pronto Extraction Catheter Regulation Number: 21 CFR 870.5150 Regulation Name: Embolectomy catheter Regulatory Class: Class II Product Code: QEZ
Dear Gregory Sachs:
The Food and Drug Administration (FDA) is sending this letter to notify you of an administrative change related to your previous substantial equivalence (SE) determination letter dated December 19, 2003. Specifically, FDA is updating this SE Letter because FDA has created a new product code to better categorize your device technology.
Please note that the 510(k) submission was not re-reviewed. For questions regarding this letter please contact Gregory O'Connell, OHT2: Office of Cardiovascular Devices, (301) 796-6075, Gregory. Oconnell@FDA.HHS.gov.
Sincerely,
Digitally signed by Gregory W. Gregory W. O'connell -S O'connell -S Date: 2021.10.08 10:16:28 -04'00'
Gregory O'Connell Assistant Director DHT2C: Division of Coronary and Peripheral Intervention Devices OHT2: Office of Cardiovascular Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
1
DEPARTMENT OF HEALTH & HUMAN SERVICES
Public Health Service
Image /page/1/Picture/2 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo features a stylized eagle with three stripes forming its body and wings. The eagle is enclosed in a circle with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the circumference of the circle.
DEC 1 9 2003
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Vascular Solutions, Inc. c/o Mr. Gregory Sachs Director of Regulatory Affairs 6464 Sycamore Court, Minneapolis, MN 55369
Re: K032763
Vascular Solutions ProntoTM Extraction Catheter Regulation Number: 21 CFR 870.5150 Regulation Name: Embolectomy Catheter Regulatory Class: II Product Code: 74 DXE Dated: December 8, 2003 Received: December 9, 2003
Dear Mr. Sachs:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
2
Page 2 - Mr. Gregory Sachs
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4586. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours.
Alysa D. Hervey for
Bram Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
3
Indications for Use Statement
510(k) Number:
1632163
Device Name:
Vascular Solutions Pronto™ Extraction Catheter
Indications for Use: The Pronto™ Extraction Catheter is indicated for the removal of fresh, soft emboli and thrombi from vessels in the arterial system.
PRESCRIPTION USE X
SDM for BDZ
12/18/03
Elisa D. Htz for Brian Zucherm
(Division Sign-off) 12/18/03
(Division sign-on
Division of Cardiovascular Devices
510(k) Number K032763(SM. K
13
4
DEC 1 9 2003
510(K) SUMMARY OF SAFETY AND EFFECTIVENESS
| Common/Usual Name: | Embolectomy Catheter |
|---|---|
| Product Trade Name: | PRONTO Extraction Catheter |
| Classification Name: | Unclassified |
| Product Code, DXE | |
| Manufacturer: | Vascular Solutions, Inc. |
| 6464 Sycamore Court | |
| Minneapolis, Minnesota 55369 | |
| Establishment Registration: | 2134812 |
| Contact: | Gregory Sachs |
| Director of Regulatory Affairs | |
| (763) 656-4210 phone | |
| (763) 656-4253 fax | |
| Performance Standards: | No performance standards have been developed under |
| section 514 for this device. |
Device Description:
The Pronto extraction catheter is a dual lumen catheter with related accessories. The extraction lumen allows for the aspiration and removal of emboli/thrombi using the included syringe, extension line and stopcock. The catheter has a rounded distal tip with a protected, sloped opening of the extraction lumen to facilitate advancement of the catheter into the blood vessel and maximize extraction of emboli/thrombi through the extraction lumen. Incorporated within the catheter distal tip is a non-blood contacting radiopaque marker for fluoroscopic visualization. The catheter is a monorail design with a distal flexible region and a proximal stiff region. The distal portion of the catheter is coated with Tween (Polysorbate 80); this coating is to lubricate the catheter for ease of use. The catheter has an approximate outer diameter of 0.065 inches, allowing delivery through standard 6Ft. guide catheters. The smaller wire lumen of the catheter is able to accommodate guide wires that are ≤ 0.014" in diameter. The catheter will be available in working lengths of 40 to 145 cm, in increments of 15 cm. The proximal end of the catheter incorporates a standard luer adapter to facilitate the attachment of the catheter to the included extension line, stopcock, and syringe. A 74 micron filter basket is included for assistance in filtering the blood removed during the procedure for laboratory analysis of thrombus.
Intended Use:
The Pronto Extraction Catheter is indicated for the removal of fresh, soft emboli and thrombi from vessels in the arterial system.
5
Summary of Non-Clinical Testing:
Testing conducted included assessments of the design verification of the Pronto Extraction Festange with biocompatibility assessments. The results of this battery of tests confirmed the suitability of the Pronto Extraction Catheter for its intended use.
Summary of Clinical Testing:
No clinical evaluations of this product have been conducted.
Predicate Devices:
The intended use of the Pronto Extraction Catheter is similar to the intended use of the Fogarty Thru-Lumen Embolectorny Catheter, the American Biomed Embolectomy Catheter and the LeMaitre Embolectomy Catheter.
Conclusions:
The Pronto Extraction. Catheter is substantially equivalent to the Fogarty Thru-Lumen Embolectomy Catheter, the American Biomed Embolectomy Catheter and the LeMaitte Embolectomy Catheter. The testing performed confirms that the Pronto Extraction Catheter will perform as intended.
6
Image /page/6/Picture/2 description: The image shows the seal of the Department of Health & Human Services - USA. The seal is circular and contains the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. In the center of the seal is a stylized image of an eagle with its wings spread. The eagle is facing to the right and has three lines representing its feathers.
DEC 1 9 2003
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Vascular Solutions, Inc. c/o Mr. Gregory Sachs Director of Regulatory Affairs 6464 Sycamore Court, Minneapolis, MN 55369
K032763 Re:
Vascular Solutions Pronto™ Extraction Catheter Regulation Number: 21 CFR 870.5150 Regulation Name: Embolectomy Catheter Regulatory Class: II Product Code: 74 DXE Dated: December 8, 2003 Received: December 9, 2003
Dear Mr. Sachs:
We have reviewed your Section 510(k) premarket notification of intent to market the device we nave teviewed your becament on the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to conninered prior to ritly 20, 2014 11 accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The I ou may, dicrerore, manos of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can hay be subject to such adderal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
7
Page 2 - Mr. Gregory Sachs
Please be advised that FDA's issuance of a substantial equivalence determination does not mean Please be advised that FDA's issuance or a substantin other requirements of the Act
that FDA has made a determination that your device complies. You must that FDA has made a determination macyountion administed by other Federal agencies. You must or any Federal statures and regulations administered of registration and listing (2).
comply with all the Act's requirements, including, but not ansation spaction regultement comply with all the Act s requirements, mename, comments requirements as set
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice the electronic CFR Part 807); labeling (21 CFR Part 801); good if applicable, the electronic
forth in the quality systems (QS) regulation (21 CFR Part 820); and if any 1000 1050 forth in the quality systems (QS) regulation (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) This letter will allow you to begin marketing your antial equivalence of your device to a legally premarket notification. The PDA miding of substantal vour device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of additionally 21 CFK Part 809.10 for miry, for questions on the promotion and advertising of Compliance at (301) 594-4580. Tidatonenty Niance at (301) 594-4639. Also, please note the your device, please comact the other of concern to premarket notification" (21CFR Part 807.97).
regulation entitled, "Misbranding by reference to premarket and secured from t Other general information on your responsibilities under the Act may be obtained from the Other general information on your responsionated and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
Elisa D. Herry for
Bram Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
8
Indications for Use Statement
510(k) Number:
Device Namc:
Vascular Solutions Pronto™ Extraction Catheter
Indications for Use: The Pronto™ Extraction Catheter is indicated for the removal of fresh, soft emboli and thrombi from vessels in the arterial system.
PRESCRIPTION USE X
984 for BDZ
12/18/03
Qlisabeth Htz for Brian Zucherm
12/18/03
(Division Sign-off)
Division of Cardiovascular Devices
510(K) Number K032763(SM.K